AzTrials
AzTrials

Maxillary RetrusionNCT05446714

Evaluation of the Effect of Three Types of Rapid Maxillary Expanders (Conventional, Hybrid and MSE)

A study testing CH 4 band, HH 2 bands and MSE 2 bands and 4 in people with Maxillary Retrusion and Nasal Airway Obstruction, run by Al-Azhar University at 1 site in Egypt.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Aim of the study: To compare radiographically the morphometric changes in the nasal airway after using three types of rapid maxillary expansion (RME) conventional hyrax (CH), hybrid hyrax (HH) and maxillary skeletal expander (MSE) using cone beam computed tomography (CBCT). Read more about this study

Who is it for?
Ages 11 to 18 years
Conditions the study is for
Maxillary Retrusion, Nasal Airway Obstruction
What is being tested?
CH 4 band, HH 2 bands and MSE 2 bands and 4
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
54 participants
Where
1 siteEgypt
Study dates
30 Apr 2022to 20 Jun 2025
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 11 to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Patients suffering maxillary collapse with a skeletal background
  • Patients with unilateral or bilateral posterior crossbite.
  • Patients with reduced or average anterior face height.
  • Patients with no periodontal disease.
  • Patients with good oral hygiene and general health.
  • No systemic diseases that may affect bone quality or interfere with orthodontic treatment.
  • Patients with erupted maxillary permanent first molars and premolars.
  • Patients with no previous orthodontic treatment.

Who cannot join

  • previous treatment
  • syndromes
  • cleft lip and palate

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Cairo

    Cairo

Other trials in Egypt

About this study

Official title: Evaluation of Three Types of Rapid Maxillary Expanders (Conventional, Hybrid, And MSE) on Maxilla in Adolescent A Randomized Clinical Trial - CBCT Study

Aim of the study: To compare radiographically the morphometric changes in the nasal airway after using three types of rapid maxillary expansion (RME) conventional hyrax (CH), hybrid hyrax (HH) and maxillary skeletal expander (MSE) using cone beam computed tomography (CBCT).

Read the detailed description

Abstract Aim of the study: To compare radiographically the morphometric changes in the nasal airway after using three types of rapid maxillary expansion (RME) conventional hyrax (CH), hybrid hyrax (HH) and maxillary skeletal expander (MSE) using cone beam computed tomography (CBCT).

Material and Methods: A total sample of thirty CBCT of patients presented with constricted maxilla with mean age of 14±3Y was randomized in to three groups. Group 1 CH, group 2 HH and group 3 MSE.

CBCT records were taken before(T1) and after six months (T2) of RME; the Airway was segmented and quantified using software (version 5.3.4.39USA).

Being tested
CH 4 band, HH 2 bands, MSE 2 bands and 4
Medical subject headings
Retrognathia, Nasal Obstruction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CH 4 bandDevice

    Also called rapid palatal expansion, Orthodontic rapid maxillary expansion

    expansion of maxilla and observation improvement of the air way

  • HH 2 bandsDevice

    expansion of maxilla and observation improvement of the air way

  • MSE 2 bands and 4Device

    expansion of maxilla and observation improvement of the air way

Study groups in NCT05446714
Study groupRoleWhat they receive
conventional hyraxActive comparatorCH 4 BANDS for expansion of maxilla and observation improvement of the air way
Receives: Device: CH 4 band
Hybrid hyraxActive comparatorHH 2 BANDS for expansion of maxilla and observation improvement of the air way
Receives: Device: HH 2 bands
Maxillary skeletal expanderActive comparatorMSE 2 BANDS AND 4 for expansion of maxilla and observation improvement of the air way
Receives: Device: MSE 2 bands and 4

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Molar Distance:

    distance in milimeter from mesiolingual cusp of upper first molar in one side to mesiolingual cusp of upper first molar in the other CBCT Measurements software

    Measured: 6 months

Secondary outcomes (3)
  1. Molar Inclination

    amount of degree of Molar inclination change before and after maxillary expansion which measured from the long axis of upper first molar to palatal plane by CBCT Evaluation

    Measured: 6 months

  2. Maxillary Width

    amount of maxillary width changes by CBCT Evaluation

    Measured: 6 months

  3. Temporomandibular Joint

    CBCT Evaluation

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Jul 2022
  2. Study start30 Apr 2022
  3. Primary completion19 Nov 2023
  4. Study completion20 Jun 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
54 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05446714
Sponsor's protocol ID
775/220
Other IDs
Ahmed, lecturer
Status last verified
Apr 2025
First submitted
20 Jun 2022
Last updated
25 Apr 2025
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: CBCT Measurements

Publications

  • Gracco A, Malaguti A, Lombardo L, Mazzoli A, Raffaeli R. Palatal volume following rapid maxillary expansion in mixed dentition. Angle Orthod. 2010 Jan;80(1):153-9. doi: 10.2319/010407-7.1.

    PubMed 19852655
  • Lagravere MO, Major PW, Flores-Mir C. Long-term skeletal changes with rapid maxillary expansion: a systematic review. Angle Orthod. 2005 Nov;75(6):1046-52. doi: 10.1043/0003-3219(2005)75[1046:LSCWRM]2.0.CO;2.

    PubMed 16448254

Questions about this trial

What is this clinical trial studying?

A study testing CH 4 band, HH 2 bands and MSE 2 bands and 4 in people with Maxillary Retrusion and Nasal Airway Obstruction, run by Al-Azhar University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 25 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 25 Apr 2025). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Molar Distance: (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05446714, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Apr 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in